Articles tagged with Mastectomy
A new study by Georgetown researchers found that nipple sparing mastectomy is a safe and effective option for women with breast cancer. The procedure, which removes breast tissue while keeping the skin and nipple intact, showed no signs of cancer recurrence or development in 162 patients over 21 years.
A University of Maryland study found that young women with early-stage breast cancer who undergo lumpectomy and radiation have similar survival rates as those who undergo mastectomy. The analysis of nearly 15,000 patients showed no difference in overall or breast cancer-specific survival between the two groups.
A study published in Journal of the National Cancer Institute found that breast cancer recurrence rates can vary significantly based on the treating surgeon. The researchers analyzed data from over 1,000 women with ductal carcinoma in situ and discovered that positive or close margins following surgery substantially compromised disease...
A study by the Radiological Society of North America found that annual mammography between ages 40 and 50 significantly reduces mastectomy rates. The researchers analyzed data from 971 women diagnosed with breast cancer and treated at a UK hospital, concluding that yearly screening improves breast conservation outcomes.
Studies identified that postmastectomy irradiation triples the risk for an unplanned return to the operating room and immediate breast reconstruction increases that risk eight-fold. Women considering immediate reconstruction may benefit from a sentinel lymph node biopsy prior to mastectomy.
Prophylactic mastectomy and salpingo-oophorectomy significantly reduce breast and ovarian cancer risks in women with BRCA1/2 mutations. The study found that risk-reducing mastectomy decreased breast cancer risk, while salpingo-oophorectomy lowered ovarian cancer risk.
A global study of nearly 10,000 women with early breast cancer found significant variations in treatment approaches across nine countries. Women with T1 tumours were more likely to receive breast-conserving surgery, while those with T2 tumours underwent mastectomies at varying rates.
Two new studies shed light on treatment options for women carrying BRCA1 and BRCA2 genetic mutations, which predispose them to breast cancer. Prophylactic mastectomy was found to have little impact on disease-free or overall survival, while breast conserving therapy with chemotherapy reduced recurrence rates in the breast.
Researchers found that women who have been diagnosed with breast cancer tend to overestimate their risk of developing cancer in the other breast. After counseling and a 12-month delay, most patients reconsidered and opted against prophylactic surgery.
A study found that contralateral prophylactic mastectomy is associated with improved 5-year breast cancer-specific survival rates for younger women with early-stage, estrogen-receptor negative tumors. However, the benefit is small and does not apply to most women with breast cancer.
Researchers at OU Health Sciences Center have developed a new treatment that kills large breast cancer tumors and reduces the need for mastectomies by almost 90 percent. The treatment, called Focused Microwave Thermotherapy, uses microwave technology to kill cancer cells, allowing women to save their breast tissue.
A study of nearly 2,000 women with breast cancer found that 75.4% received breast-conserving surgery as initial therapy, while 23% underwent mastectomy. The results suggest that most surgeons recommend local therapy options and that patient preferences play a role in shaping treatment choices.
A study found that breast-conserving surgery was offered to the majority of patients, with surgeons' recommendations and patient preferences playing key roles. The study suggests that increased patient involvement in breast surgery decisions is associated with greater probability of mastectomy.
A new study found significant socioeconomic disparities in the use of breast-conserving surgery (BCS) for older women with nonmetastatic invasive breast cancer. BCS was more widely used in younger patients, areas with high education levels, and metropolitan regions.
A new study finds that the number of women opting for prophylactic mastectomies is rising, particularly among those with cancer in one breast. Despite limited information available, the surgery appears to be increasing, but its benefits and risks should be carefully considered.
A new study found that patients who were more involved in their treatment decisions were more likely to have a mastectomy, regardless of racial or ethnic group. Patient attitudes about surgery, family and friend opinions, concern about recurrence, and body image also influenced surgical choices.
Women with BRCA gene mutations strongly favor preventive mastectomy as the most effective way to reduce their risk and fears of developing breast cancer. The study found that over 80% of these women ultimately underwent the procedure, highlighting the significant impact of genetic testing on medical decision-making.
A recent study found that patients from higher-income and more educated communities are more likely to undergo immediate breast reconstruction after mastectomy. The research highlights the importance of community demographics in influencing access to this life-changing procedure.
A recent ASPS study found that women who have breast reconstruction after an elective mastectomy are satisfied with their decision and have low complication rates. The study revealed a 98% satisfaction rate among patients who had bilateral prophylactic mastectomy, with 100% willing to undergo the procedure again.
Researchers at Mayo Clinic found a correlation between women who underwent pre-surgical breast MRI and an increased rate of mastectomy. The study suggests that MRI may lead to greater anxiety, prompting patients and physicians to choose mastectomy over lumpectomy.
Preliminary research suggests that high-risk women with breast cancer who don't have a BRCA1/2 mutation may be at a higher risk of developing a second breast cancer. The study supports the use of prophylactic mastectomy as an option for these women, but raises questions about the role of sentinel node biopsy.
A study of 250 BRCA carriers found that prophylactic mastectomy significantly reduces the risk of developing breast cancer, with only one case detected. The cost of ongoing surveillance is high and can be stressful for patients, while intensive screening may not always detect cancer at an early stage.
A new study found that while MRI has a high false positive rate, it still detects genuine breast cancer cases effectively. However, the rate of false positives does not impact a woman's decision to undergo prophylactic mastectomy.
A new study from the University of Michigan Comprehensive Cancer Center found that only a third of breast cancer patients discussed reconstruction options with their surgeon. Women who did discuss reconstruction were four times more likely to choose a mastectomy, highlighting the importance of informed decision-making in surgical choices.
A study found a 150% increase in women choosing contralateral prophylactic mastectomy when cancer is confined to one breast. Despite this, researchers caution that the procedure may not improve overall survival and raise concerns about unnecessary invasive treatment.
A study published in the Journal of Clinical Oncology found that women with breast cancer who undergo preventive mastectomies are satisfied with their decision and have a lower risk of developing future breast cancer. The survey also revealed that concerns about breast cancer were more common among women without the procedure.
Contralateral prophylactic mastectomies (CPM) reduce risk of future breast cancer, but may lead to negative feelings towards body appearance and loss of sense of femininity. The study found that satisfaction levels were higher in women who underwent a simple mastectomy compared to those who had bilateral prophylactic mastectomies.
Performing a sentinel lymph node biopsy as an outpatient procedure prior to mastectomy can help guide the optimal surgical procedure for patients. This approach allows for more informed decisions regarding radiation therapy and reconstruction, potentially improving cosmetic results.
A recent study found that foreign-born Asian American and Pacific Island women are significantly less likely to receive breast-conserving surgery than non-Hispanic white women, despite similar demographic and tumor characteristics. Language barriers and cultural factors may contribute to these disparities.
Women with breast implants after mastectomy have a lower mortality rate from breast cancer compared to those without implants, suggesting that breast implants may improve survival. The study of over 4,000 women found that implant recipients had a 12.4% mortality rate, half that of non-implant recipients.
A study by the American College of Radiology found that MRI detected more malignant lesions than mammography in women with breast cancer, including larger and more aggressive cancers. The research suggests using MRI to identify potential cancerous areas and downsize mastectomies for some patients.
A study of 128 women found that immediate breast reconstruction after mastectomy did not delay the initiation of postoperative chemotherapy. The overall rate of wound complications was 15.5%, with higher rates in patients who underwent immediate breast reconstruction, but these complications did not affect chemotherapy timing.
African-American women are less likely to undergo immediate or delayed breast reconstruction after mastectomy compared to Caucasian, Hispanic, Asian, and Middle Eastern women. Physicians' referral patterns and patient acceptance also contribute to these racial discrepancies.
A recent study by the University of Michigan Comprehensive Cancer Center found that breast cancer patients who made their own treatment decisions were more likely to choose mastectomies over breast-conserving surgeries. The study also revealed that fewer than a third of women with mastectomies received reconstructive surgery, and those...
A new study found a significant disparity in breast conservation rates between countries, with Poland having the lowest rate of only 2% and the USA the second-highest at 56%. The variation was attributed to factors such as tumour characteristics, access to radiotherapy, and screening programmes.
A new study found that women with ductal carcinoma in situ (DCIS) who undergo conservation treatment have a similar rate of survival compared to those who undergo mastectomy. Close monitoring and regular screenings are crucial for successful treatment and early detection of recurrence.
Women experience a range of physical symptoms, including hot flashes and vaginal dryness, following breast cancer treatment. Mood and emotional functioning are similar among all women at the end of primary treatment.
A study of women in Ontario who had double mastectomies between 1991 and 2000 found that two-thirds reported no change or improvement in their sexual functioning. The majority also showed no decline in self-image, with nearly half reporting an improved self-image after surgery.
A study published in Archives of Surgery examined 564,267 outpatient surgical procedures and found that risk factors include advanced age, prior hospitalization, and invasive surgeries. The results highlight the importance of proper assessment and resource availability for high-risk patients undergoing outpatient surgery.
A study by French researchers found that young breast cancer patients who undergo lumpectomy have a higher risk of late recurrence compared to those who opt for mastectomy. The risk is particularly high among women under 40 years old.
A University of Toronto study reveals that women who undergo prophylactic bilateral mastectomy significantly overestimate their breast cancer risk, except for those with BRCA1 and BRCA2 mutations. The study suggests that formal genetic counselling is essential for women considering the procedure to make an informed decision.
A pilot study by a consultant surgeon found that breast reconstruction surgery takes longer and results in more complications, out-patient appointments, and additional surgeries. The study showed that mastectomies with breast reconstruction took 7.1 days to complete, compared to 5.6 days for those without reconstruction.
A study found that surgeons rarely offer women a choice between mastectomy and breast-conserving surgery, despite medical appropriateness. Women's perceptions of receiving a choice differ significantly from surgeons' perceptions, with female surgeons focusing on security and male surgeons prioritizing femininity.
Researchers found that women who received predictive genetic testing for hereditary breast and ovarian cancer took practical measures, such as regular medical exams, rather than experiencing significant distress. About 10% opted for prophylactic mastectomy, while 37% had already undergone oophorectomy before testing.
A Mayo Clinic study found that prophylactic mastectomy reduced the risk of breast cancer in women with BRCA1 and BRCA2 mutations by 89.5% to 100%. The study followed 26 high-risk women for 13.4 years without developing breast cancer, despite predicted risks of 6-9 cases.
The incidence of outpatient total mastectomy increased significantly between 1990 and 1996, particularly in states like Colorado and Maryland. Insurance coverage also played a role, with Medicaid patients being more likely to require hospital stays.
A new study led by the University of Michigan found that breast reconstruction during mastectomy significantly improves emotional, social, and functional well-being. Women who opted for simultaneous reconstruction experienced a larger psychological boost than those who waited for reconstructive surgery later.